NEO
Neogenomics, Inc. Earnings
$8.02
Earnings Summary
Revenue | $190.17Mn |
Net Profits | $-9.88Mn |
Net Profit Margins | -5.2% |
Neogenomics, Inc.’s revenue jumped 10.56% since last year same period to $190.17Mn in the Q4 2025. On a quarterly growth basis, Neogenomics, Inc. has generated 1.26% jump in its revenue since last 3-months.
Neogenomics, Inc.’s net profit jumped 35.52% since last year same period to $-9.88Mn in the Q4 2025. On a quarterly growth basis, Neogenomics, Inc. has generated 63.58% jump in its net profits since last 3-months.
Neogenomics, Inc.’s net profit margin jumped 41.68% since last year same period to -5.2% in the Q4 2025. On a quarterly growth basis, Neogenomics, Inc. has generated 64.03% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.01 |
EPS Estimate Current Year | 0.01 |
Neogenomics, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.01 - a -71.5% fall from last quarter’s estimates.
Neogenomics, Inc.’s earning per share (EPS) estimates for the current year stand at 0.01.
Key Ratios
Earning Per Share (EPS) | 0 |
Neogenomics, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Neogenomics, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-05 | 0.01 | 0 | -100% |





